Skip to main content

Atrial Fibrillation

Featured Article
Researchers recently examined the safety and efficacy of apixaban for anticoagulation in patients with atrial fibrillation scheduled for cardioversion.
A drug is associated with an increased risk of mortality among patients with atrial fibrillation with and without heart failure, recent research suggests.

Interactive Features

Calcium channel blockers improve exercise capacity in patients with permanent atrial fibrillation (AF), but beta-blockers have the opposite effect, according to a new study from Norway.
Back to Top